PRESS RELEASE published on 04/22/2025 at 22:00, 1 year 2 months ago Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3 Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE published on 04/22/2025 at 22:00, 1 year 2 months ago Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025 Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF published on 04/18/2025 at 18:05, 1 year 2 months ago ABIVAX: Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF published on 04/18/2025 at 18:05, 1 year 2 months ago ABIVAX : Capital Social et Droits de Vote au 31 Mars 2025 Euronext Paris Droits De Vote Capital Social Actions Abivax
BRIEF published on 04/18/2025 at 18:05, 1 year 2 months ago ABIVAX: Détails sur le Capital Social et les Droits de Vote au 31 Mars 2025 Euronext Paris Droits De Vote Capital Social Biotechnologie Abivax
BRIEF published on 04/18/2025 at 18:05, 1 year 2 months ago ABIVAX: Details of Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Biotechnology Abivax
PRESS RELEASE published on 04/18/2025 at 18:00, 1 year 2 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25. ABIVAX communique le nombre total d'actions et de droits de vote. La société de biotechnologie Abivax se concentre sur le développement de traitements pour les maladies inflammatoires chroniques Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
PRESS RELEASE published on 04/18/2025 at 18:00, 1 year 2 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25. ABIVAX communique le nombre d'actions et de droits de vote au 31.03.25 conformément aux réglementations de l'AMF Droits De Vote Actions AMF Abivax Réglementation
BRIEF published on 03/27/2025 at 18:05, 1 year 2 months ago ABIVAX: Update of share capital and voting rights Share Capital Voting Rights Biotechnology AMF Abivax
BRIEF published on 03/27/2025 at 18:05, 1 year 2 months ago ABIVAX : Mise à jour du capital social et des droits de vote Droits De Vote Capital Social Biotechnologie AMF Abivax
Published on 06/23/2026 at 01:55, 2 hours 25 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 4 hours 55 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 5 hours 15 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 7 hours 15 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 8 hours 35 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/23/2026 at 04:05, 15 minutes ago Aosom France x FFHandball: Enhancing the Fan Experience Through Home & Outdoor Living Solutions
Published on 06/23/2026 at 01:35, 2 hours 45 minutes ago DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 7 hours 13 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 7 hours 30 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 7 hours 47 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 18:00, 10 hours 20 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION